Phillips-Medisize, a Molex company, has debuted the Aria Smart Autoinjector platform consisting of a smart injection device with a reusable electronic drive unit and single-use, disposable cassettes. The autoinjector was developed to ease patient use and address growing sustainability requirements. 

“With the Aria Smart Autoinjector, we are disrupting this sector with a game-changing platform that brings the right functionality to market in the right form factor at the right time,” said Kevin Deane, VP, Innovation at Phillips-Medisize, in a news release. “Our goal from the outset has been to develop an injector that patients love, combining the simplicity of current disposable devices with the superior performance, sustainability, and connectivity possible through an electronic, reusable device.”  

An April 2021 survey commissioned by Molex and Phillips-Medisize on “Digital Health and the Future of Pharma” shows that digitized drug delivery is on the rise, but there are challenges with usability and sustainability.  

Phillips-Medisize developed the Aria Smart Autoinjector with the compact size and “look and feel” of existing disposable autoinjectors in mind, it reported. Users are guided by sound and light signals that indicate dose progress and completion, and sleeve-triggered activation and needle safety features also are provided.

Aria’s reusable drive and disposable cassette help pharmaceutical companies meet growing sustainability mandates while addressing patient preferences for a greener drug delivery device, Phillips-Medisize reported. 

Other features include built-in Bluetooth and optional RFID connectivity for seamless data sharing of time-stamped dosing logs with smartphones, tablets, and mobile healthcare apps. The autoinjector can accommodate both 1ml and 2.25ml syringes in a common cassette, and a wide range of drug viscosities can be delivered by the platform.